KISHAN SHAH: Open Payments
NPI 1922622687 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 25 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $75 · 2025 $561
Food & beverage: $452Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $174 |
| Neurocrine BioSciences, Inc. | 6 | $118 |
| Alkermes, Inc. | 4 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Bausch Health US, LLC | 3 | $54 |
| Eisai Inc. | 1 | $23 |
| Indivior Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Corium, LLC | 1 | $15 |
Products named: INGREZZA, ARISTADA, WELLBUTRIN, AUSTEDO XR, INVEGA SUSTENNA, Leqembi, SPRAVATO, SUBLOCADE.
Industry payments across NJ — which companies pay providers there.
